Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery

Launched by AESCULAP AG · Jul 28, 2023

Keywords

ClinConnect Summary

This clinical trial is studying two different types of stitches (sutures) used to close wounds after surgery, specifically looking at whether a special stitch called Novosyn® CHD, which is coated with a germ-fighting substance, helps reduce the risk of infections compared to a standard stitch called Polyglactin 910. The researchers want to find out if using the Novosyn® CHD stitch can lead to fewer surgical site infections, which are infections that can occur where the surgery was performed.

To participate in this study, you need to be at least 18 years old and undergoing either an emergency or planned laparotomy (a type of surgery that opens the abdomen) or laparoscopic surgery (a less invasive surgery with small incisions). You will need to give your written consent to join the trial. If you have an allergy to chlorhexidine, the substance in the Novosyn® CHD stitch, you won't be eligible. Participants can expect close monitoring for any complications after their surgery, which can help with early diagnosis and better overall care. This study is currently recruiting, and anyone interested should discuss it with their healthcare provider.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing an emergency or elective laparotomy or laparoscopic surgery.
• • Written informed consent
• • Age≥ 18 years
• • Not incapacitated patient
• Exclusion Criteria:
• • No exclusion criteria except patients with allergy or hypersensitivity to chlorhexidine